Schwartzkopf, C. D., Liu, G., Hadcock, J. R., Currie, M. G., Masferrer, J. L., & Jones, J. E. (2020). SUN-662 Praliciguat, a Clinical-Stage Soluble Guanylate Cyclase Stimulator, Improves Lipid Handling and Insulin Sensitivity in Diet-Induced Obese Mice. J Endocr Soc.
Chicago Style CitationSchwartzkopf, Chad D., Guang Liu, John R. Hadcock, Mark G. Currie, Jamie L. Masferrer, and Juli E. Jones. "SUN-662 Praliciguat, a Clinical-Stage Soluble Guanylate Cyclase Stimulator, Improves Lipid Handling and Insulin Sensitivity in Diet-Induced Obese Mice." J Endocr Soc 2020.
MLA CitationSchwartzkopf, Chad D., et al. "SUN-662 Praliciguat, a Clinical-Stage Soluble Guanylate Cyclase Stimulator, Improves Lipid Handling and Insulin Sensitivity in Diet-Induced Obese Mice." J Endocr Soc 2020.